Incorporation of CXCR4 into CAR-NK constructs does not represent a second antigenic target but rather a homing modification to enhance NK-cell migration toward the bone marrow niche—where MM cells predominantly reside. The gene discussed is CXCR4; the disease is Miyoshi myopathy.